David A. Brown

20.4k total citations · 1 hit paper
363 papers, 14.7k citations indexed

About

David A. Brown is a scholar working on Molecular Biology, Immunology and Rheumatology. According to data from OpenAlex, David A. Brown has authored 363 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Molecular Biology, 73 papers in Immunology and 70 papers in Rheumatology. Recurrent topics in David A. Brown's work include GDF15 and Related Biomarkers (61 papers), Macrophage Migration Inhibitory Factor (52 papers) and Nutrition and Health in Aging (39 papers). David A. Brown is often cited by papers focused on GDF15 and Related Biomarkers (61 papers), Macrophage Migration Inhibitory Factor (52 papers) and Nutrition and Health in Aging (39 papers). David A. Brown collaborates with scholars based in United States, Australia and United Kingdom. David A. Brown's co-authors include Samuel N. Breit, Asne R. Bauskin, Vicky Wang-Wei Tsai, Russell L. Moore, Saame Raza Shaikh, Brian O’Rourke, W.K. Glass, Yasmin Husaini, Tao Liu and Paul E. Sawchenko and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

David A. Brown

351 papers receiving 14.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial function as a therapeutic target in heart failure

2016 562 citations David A. Brown, Justin B. Perry et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Brown United States	66	5.0k	4.3k	4.0k	3.2k	1.8k	363	14.7k
Ron A. Wevers Netherlands	65	8.3k 1.7×	2.1k 0.5×	3.9k 1.0×	967 0.3×	788 0.4×	490	17.3k
Hideo Kimura Japan	70	6.7k 1.3×	1.4k 0.3×	4.7k 1.2×	1.6k 0.5×	520 0.3×	224	21.7k
Mark G. Currie United States	63	4.6k 0.9×	869 0.2×	5.2k 1.3×	1.5k 0.5×	846 0.5×	219	17.0k
Giuseppe Cirino Italy	72	5.5k 1.1×	589 0.1×	4.7k 1.2×	2.4k 0.7×	653 0.4×	288	17.9k
Jay W. Heinecke United States	99	8.4k 1.7×	977 0.2×	6.4k 1.6×	8.9k 2.8×	1.1k 0.6×	266	29.3k
Takao Shimizu Japan	87	14.5k 2.9×	713 0.2×	5.8k 1.5×	5.0k 1.6×	2.2k 1.2×	494	28.4k
Makoto Suematsu Japan	77	10.6k 2.1×	636 0.1×	3.3k 0.8×	3.0k 1.0×	1.4k 0.8×	474	22.6k
Owen W. Griffith United States	54	6.5k 1.3×	615 0.1×	5.3k 1.3×	1.2k 0.4×	882 0.5×	142	18.2k
Henry Jay Forman United States	77	13.5k 2.7×	679 0.2×	3.9k 1.0×	2.8k 0.9×	1.0k 0.6×	286	27.3k
Bernard Babior United States	71	9.8k 1.9×	1.1k 0.3×	5.3k 1.3×	9.8k 3.1×	808 0.5×	196	23.3k

Countries citing papers authored by David A. Brown

Since Specialization

Citations

This map shows the geographic impact of David A. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Brown more than expected).

Fields of papers citing papers by David A. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Brown. The network helps show where David A. Brown may publish in the future.

Co-authorship network of co-authors of David A. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Brown. A scholar is included among the top collaborators of David A. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Brown. David A. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scott, Elizabeth, Richard B. Banati, David A. Brown, et al.. (2024). Neuroimmune-mediated neuropsychiatric syndromes: perspectives for standardised diagnostics and personalised care. 1.

Cho, Ann‐Na, et al.. (2024). Proteome profiling of cerebrospinal fluid using machine learning shows a unique protein signature associated with APOE4 genotype. Aging Cell. 24(4). e14439–e14439. 1 indexed citations

Wu, Linda, Matteo S. Carlino, David A. Brown, et al.. (2023). Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-peptide Loss and Pancreatic Atrophy. The Journal of Clinical Endocrinology & Metabolism. 109(5). 1301–1307. 7 indexed citations

Brown, David A., et al.. (2023). An obstetrician-gynecologist’s review of hernias: risk factors, diagnosis, prevention, and repair. American Journal of Obstetrics and Gynecology. 229(3). 214–221. 1 indexed citations

Padhi, Abinash, et al.. (2022). Combination of the natural product mensacarcin with vemurafenib (Zelboraf) combats BRAF mutant and chemo-resistant melanoma in vitro by affecting cell metabolism and cellular migration. SHILAP Revista de lepidopterología. 6. 100070–100070. 2 indexed citations

McDaniel, Dylan K., Veronica M. Ringel‐Scaia, Holly A. Morrison, et al.. (2019). Pulmonary Exposure to Magnéli Phase Titanium Suboxides Results in Significant Macrophage Abnormalities and Decreased Lung Function. Frontiers in Immunology. 10. 2714–2714. 13 indexed citations

Jiang, Lele, Hui Li, Joanna M. Rybicka, et al.. (2012). Intracellular chloride channel protein CLIC1 regulates macrophage functions via modulation of phagosomal acidification. Journal of Cell Science. 125(Pt 22). 5479–88. 75 indexed citations

Brown, David A., Sharon L. Hale, Carlos del Río, et al.. (2012). Abstract 10740: Bendavia, a Mitochondria-targeting Peptide, Reduces Reperfusion Injury and Reactive Oxygen Species Levels Through a Mechanism Independent of Direct Oxygen Radical Scavenging: A Multicenter Study. Circulation. 126. 1 indexed citations

Alvero, Ayesha B., Michele K. Montagna, Jennie C. Holmberg, et al.. (2011). Targeting the Mitochondria Activates Two Independent Cell Death Pathways in Ovarian Cancer Stem Cells. Molecular Cancer Therapeutics. 10(8). 1385–1393. 97 indexed citations

10.

Kloner, Robert A., Sharon L. Hale, Robert C. Gorman, et al.. (2011). Abstract 9581: Bendavia, a Novel Mitochondrial-Targeted Cytoprotective Compound Reduces Ischemia/Reperfusion Injury: Experience in 3 Independent Laboratories. Circulation. 124(suppl_21). 3 indexed citations

11.

Bauskin, Asne R., Lele Jiang, Xiaohe Luo, et al.. (2010). The TGF-β Superfamily Cytokine MIC-1/GDF15: Secretory Mechanisms Facilitate Creation of Latent Stromal Stores. Journal of Interferon & Cytokine Research. 30(6). 389–397. 55 indexed citations

12.

Lee, Brian Y., David A. Brown, Mark P. Molloy, et al.. (2009). Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling. Cancer Research. 69(19). 7696–7703. 86 indexed citations

13.

Liu, Ting, David A. Brown, & Brian O’Rourke. (2009). Cgp-37157 Abrogates The Adverse Effect Of Ouabain On Mitochondrial Energetics. Biophysical Journal. 96(3). 243a–243a. 2 indexed citations

14.

Yarosh, Daniel B., et al.. (2005). Calcineurin Inhibitors Decrease DNA Repair and Apoptosis in Human Keratinocytes Following Ultraviolet B Irradiation. Journal of Investigative Dermatology. 125(5). 1020–1025. 139 indexed citations

15.

Hoshi, Naoto, Takahiro Takeuchi, Shigeru Yokoyama, et al.. (2003). AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists. Nature Neuroscience. 6(6). 564–571. 204 indexed citations

16.

Myers, Russell B., David A. Brown, Denise K. Oelschlager, et al.. (1996). Elevated serum levels of p105erbB-2 in patients with advanced-stage prostatic adenocarcinoma. International Journal of Cancer. 69(5). 398–402. 25 indexed citations

17.

Brown, David A., et al.. (1994). Design Waves and Wave Spectra for Engineering Applications. 993–1007. 4 indexed citations

18.

Kelly, D. C., David A. Brown, J. S. Robertson, & K.A. Harrap. (1980). Biochemical, biophysical and serological properties of two singly enveloped nuclear polyhedrosis viruses from Heliothis armigera and Heliothis zea.. 3. 319–331. 17 indexed citations

19.

Nicoll, Charles S., H. A. Bern, & David A. Brown. (1966). OCCURRENCE OF MAMMOTROPHIC ACTIVITY (PROLACTIN) IN THE VERTEBRATE ADENOHYPOPHYSIS. Journal of Endocrinology. 34(3). 343–NP. 39 indexed citations

20.

Marley, E., G. V. R. Born, John R. Vane, et al.. (1961). PROCEEDINGS OF THE BRITISH PHARMACOLOGICAL SOCIETY. British Journal of Pharmacology and Chemotherapy. 16(1). 1–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact